Início » 10. Referências bibliográficas

10. Referências bibliográficas

  1. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002 Jan;12(1):63-8.
  2. ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2010 Aug;116(2 Pt 1):467-8.
  3. Alecsandru D, García-Velasco JA. Immunology and human reproduction. Curr Opin Obstet Gynecol. 2015 Jun;27(3):231-4.
  4. Alecsandru D, García-Velasco JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril. 2017 Jun;107(6):1273-1278.
  5. Alecsandru D, Garrido N, Vicario JL, Barrio A, Aparicio P, Requena A, García-Velasco J. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum Reprod. 2014 Dec;29(12):2637-43.
  6. Baba S, Noda H, Nakayama M, Waguri M, Mitsuda N, Iso H. Risk factors of early spontaneous abortions among Japanese: a matched case-control study. Hum Reprod. 2011 Feb;26(2):466-72.
  7. Barros VI, Igai AM, Andres Mde P, Francisco RP, Zugaib M. Pregnancy outcome and thrombophilia of women with recurrent fetal death. Rev Bras Ginecol Obstet. 2014 Feb;36(2):50-5.
  8. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002 Nov-Dec;8(6):457–69. Referências bibliográficas
  9. Bennett SA, Bagot CN, Arya R. Pregnancy loss and thrombophilia: the elusive link. Br J Haematol. 2012 Jun;157(5):529-42.
  10. Bhatnagar P, Papaioannou VE and Biggers JD (1995) CSF-1 and mouse preimplantation development in vitro. Development 121,1333–1339.
  11. Boomsma CM, Kavelaars A, Eijkemans MJ, et al. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod. 2009 Jun;24(6):1427-35.
  12. Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, Liang X. Autologous plateletrich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015 Jan 15;8(1):1286-90.
  13. Clark DA. Intralipid as treatment for recurrent unexplained abortion? Am J Reprod Immunol. 1994 Dec;32(4):290-3.
  14. Clark SC and Kamen R (1987) The human hematopoietic colony-stimulating factors. Science 236,1229–1237. Duan JS (1990) Production of granulocyte colony stimulating factor in decidual tissue and its significance in pregnancy. Osaka City Med J 36,81–97.
  15. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcomeObstet Gynecol. 2008 Jul;112(1):85-92.
  16. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994 Jul;9(7):1328-32.
  17. Collin P et al. Infertility and coeliac disease. Gut. 1996;39:382-384. Disponível em Acesso em 03/06/2016.
  18. Colucci F. The role of KIR and HLA interactions in pregnancy complications Immunogenetics. 2017 Aug;69(8-9):557-565.
  19. Coulam CB, Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol. 2012 Apr;67(4):296-304.
  20. Couto E, Barini R, Zaccaria R, et al. Association of anticardiolipin antibody and C677T in methylenetetrahydrofolate reductase mutation in women with recurrent spontaneous abortions: a new path to thrombophilia? Sao Paulo Med J. 2005 Jan 2;123(1):15-20.
  21. De Braekeleer M, Dao TN. Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod. 1990 Jul;5(5):519-28. Review.
  22. de la Rochebrochard E, Thonneau P.Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod. 2002 Jun;17(6):1649-56.
  23. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005;(2):CD002859.
  24. Fatemi HM, Popovic-Todorovic B. Implantation in assisted reproduction: a look at endometrial receptivity. Reprod Biomed Online. 2013 Nov;27(5):530-8.
  25. Franasiak JM, Scott RT. Contribution of immunology to implantation failure of euploid embryos. Fertil Steril. 2017 Jun;107(6):1279-1283
  26. Gomaa MF, Elkholy AG, El-Said MM, Abdel-Salam NE. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A doubleblind placebo randomized controlled trial. Arch Gynecol Obstet. 2014 Oct;290(4):757-62.
  27. Haas DM, Ramsey OS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2013 Oct 31;10:CD003511
  28. Hanson U, Persson B, Thunell S. Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia. 1990;33(2):100–4.
  29. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 2010 Nov;120(11):4102-10.
  30. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyper- prolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. 1998 Aug;70(2):246–52.
  31. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease – effect of a gluten free diet. Gut 1989; 30.
  32. Hutton B, Sharma R, Fergusson D, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG. 2007 Feb;114(2):134-42.
  33. Hviid MM, Macklon N. Immune modulation treatments-where is the evidence? Fertil Steril. 2017 Jun;107(6):1284-1293.
  34. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002 Feb;87(2):524-9.
  35. James AH, Konkle BA, Bauer KA. Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency. Int J Womens Health. 2013 May 3;5:233-41
  36. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004734.
  37. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol. 2002 Jan-Feb;37(1):87-92.
  38. Kitaya K. Prevalence of chronic endometritis in recurrent miscarriages. Fertil Steril. 2011 Mar 1;95(3):1156-8
  39. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen. J Thyroid Res. 2011;2011:843591.
  40. Lasa JS et al. Risk of infertility in patients with celiac disease: a meta-analysis of observational studies. Arquivos de gastroenteroligia. 2014 Apr-Jun;51(2):144-50.
  41. Laschke MW, Elitzsch A, Scheuer C, Holstein JH, Vollmar B, Menger MD. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cellproliferation. Br J Pharmacol. 2006 Sep;149(2):137-44.
  42. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004 Jul;19(7):1644-6.
  43. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989 Aug;161(2):369–73.
  44. Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum Reprod Update. 2002 JulAug;8(4):333-43. Review.
  45. Matsubayashi H, Maruyama T, Ozawa N, et al. Am J Reprod Immunol. 2000 Nov;44(5):284-8.
  46. McCann JP, Nicholls DP, Verzin JA. Adult coeliac disease presenting with infertility. Ulster MedJ 1988; 57: 88-9.
  47. McFarlane XA, Bhalla AK, Reeves DE, Morgan LM,Robertson DA. Osteoporosis in treated adult celiac disease. Gut 1995; 36: 710-4.
  48. Metwally M, Saravelos SH, Ledger WL, Li TC. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril. 2010 Jun;94(1):290-5.
  49. Michelon T, Silveira JG, Graudenz M, Neumann J. Imunologia da gestação. Revista da AMRIGS. 2006 Abr-Jun;50(2):145-151.
  50. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988 Dec 22;319(25):1617-23.
  51. Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ. 2004 Nov 27;329(7477):1283-5.
  52. Morgan S, Koren G, Bozzo P. Is caffeine consumption safe during pregnancy? Can Fam Physician. 2013 Apr;59(4):361-2.
  53. Morin SJ, Treff NR, Tao X, Scott RT 3rd3, Franasiak JM, Juneau CR, Maguire M, Scott RT. Combination of uterine natural killer cell immunoglobulin receptor haplotype and trophoblastic HLA-C ligand influences the risk of pregnancy loss: a retrospective cohort analysis of direct embryo genotyping data from euploid transfers. Fertil Steril. 2017 Mar;107(3):677-683.e2.
  54. Nair RR, Khanna A, Singh R, Singh K. Association of maternal and fetal MTHFR A1298C polymorphism with the risk of pregnancy loss: a study of an Indian population and a meta-analysis. Fertil Steril. 2013 Apr;99(5):1311-1318.
  55. Nakagawa K, Kwak-Kim J, Ota K, Kuroda K, Hisano M, Sugiyama R, Yamaguchi K. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol. 2015 Apr;73(4):353-61.
  56. National Foundation for Celiac Awareness. Infertility and Celiac Disease. National Foundation for Celiac Awareness. Acesso em 06/10/2010.
  57. Ndukwe G. Recurrent embryo implantation failure after in vitro fertilisation: improved outcome following intralipid infusion in women with elevated T Helper 1 response. Hum Fertil (Camb). 2011;14(2):21–2.
  58. Nybo Andersen AM1, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000 Jun 24;320(7251):1708-12.
  59. Palomba S, Falbo A,Orio F Jr,Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2009 Nov;92(5):1646-58.
  60. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical association. Br J Obstet Gynaecol. 1993 Oct;100(10):909-13.
  61. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000112.
  62. Practice Committee of the American Society for Reproductive Medicine. The role of immunotherapy in in vitro fertilization: a guideline. Fertil Steril. 2018 Aug;110(3):387-400.
  63. Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online. 2006 Jul;13(1):24-8.
  64. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995;10:3301–4.
  65. Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and beta-2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod. 1995 Aug;10(8):2001-5.
  66. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003 Mar 15;361(9361):901-8.
  67. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril. 2004 Oct;82(4):799-804.
  68. Roussev RG, Acacio B, Ng SC, Coulam CB. Duration of intralipid’s suppressive effect on NK cell’s functional activity. Am J Reprod Immunol. 2008 Sep;60(3):258-63.
  69. Sakkas D, Jaquenoud N, Leppens G, Campana A. Comparison of results after in vitro fertilized embryos are cultured in routine medium and in co-culture on Vero cells: a randomized study. Fertil Steril. 1994;61:521–5.
  70. Salmassi A, Schmutzler AG, Schaefer S, Koch K, Hedderich J, Jonat W, Mettler L. Is granulocyte colony-stimulating factor level predictive for human IVF outcome? Hum Reprod. 2005 Sep;20(9):2434-40.
  71. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update. 2008 Sep-Oct;14(5):415-29.
  72. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod. 2009 Nov;24(11):2703-8.
  73. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014 May-Jun;20(3):429-38.
  74. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014 May-Jun;20(3):429-38.
  75. Sher KS et al. Female fertility, obstetric and gynaecological history in celiac disease. A case control study. Digestion.1994;55(4):243-6. . Acesso em 03/06/2016.
  76. Shreeve N, Sadek K. Intralipid therapy for recurrent implantation failure: new hope or false dawn? J Reprod Immunol. 2012;93:38–40.
  77. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet. 2012 Nov;29(11):1227-39.
  78. Stazi AV et al. Celiac Disease and its endocrine and nutritional implications on male reproduction. Minerva Med. 2004. Jun;95(3):243-54
  79. Stephenson MD, KuttehWH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C.Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.Hum Reprod. 2010 Sep;25(9):2203-9.
  80. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996 Jul;66(1):24-9.
  81. Sugiura-Ogasawara M, Ozaki Y, Katano K, Suzumori N, Kitaori T, Mizutani E.Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod. 2012 Aug;27(8):2297-303.
  82. Sugiura-Ogasawara M, Ozaki Y, Suzumori N. Management of recurrent miscarriage. J Obstet Gynaecol Res. 2014 May;40(5):1174-9.
  83. Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod. 2011 Aug;26(8):1971-80.
  84. Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod. 2013 Jul;28(7):1743-52.
  85. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A.Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011 May 9;342:d2616.
  86. Tuckerman E, Laird SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod. 2007 Aug;22(8):2208-13.
  87. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG. 2007 Feb;114(2):134-42.
  88. Wurfel W.,Santijohanser C. et al – High pregnancy rates with admnistration of granulocyte colony-stimulating factor in ART – patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors. Human Reproduction 2010, 25:2151-2153.
  89. Xu L, Liu XM, Zhang HY, Zhao J, Qi QW, Chang YF. Relationship between three thrombophilic gene mutations and unexplained recurrent early spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi. 2007 Mar;42(3):180-3.
  90. Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017 Feb 1;21(1):54-56.
  91. Zhang L, Xu WH, Fu XH, Huang QX, Guo XY, Zhang L, Li SS, Zhu J2, ShuJ. Therapeutic role of granulocyte colony-stimulating factor (G-CSF) for infertile women under in vitro fertilization and embryo transfer (IVF-ET) treatment: a meta-analysis. Arch Gynecol Obstet. 2018 Sep 15.
  92. Zini A. 2011. Are sperm chromatin and DNA defects relevant in the clinic? Syst Biol Reprod Med. Feb;57(1-2):78-85.
Valores e Dúvidas sobre os
Tire suas dúvida e saibas os valores dos nossos tratamentos